IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MUNARI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.799
AS - Asia 2.058
EU - Europa 806
SA - Sud America 682
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.735
SG - Singapore 802
BR - Brasile 575
CN - Cina 404
HK - Hong Kong 348
VN - Vietnam 209
UA - Ucraina 131
DE - Germania 112
FR - Francia 98
TR - Turchia 89
FI - Finlandia 87
IE - Irlanda 85
RU - Federazione Russa 85
GB - Regno Unito 68
IT - Italia 62
BD - Bangladesh 55
AR - Argentina 50
IN - India 33
ID - Indonesia 22
CA - Canada 21
ZA - Sudafrica 19
MX - Messico 18
IQ - Iraq 17
BE - Belgio 15
CO - Colombia 12
PK - Pakistan 12
SA - Arabia Saudita 11
UZ - Uzbekistan 11
EC - Ecuador 10
JP - Giappone 9
MA - Marocco 9
NL - Olanda 9
SE - Svezia 9
CL - Cile 8
JM - Giamaica 8
PL - Polonia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 6
AT - Austria 6
PY - Paraguay 6
TN - Tunisia 6
UY - Uruguay 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
NP - Nepal 5
EG - Egitto 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
PH - Filippine 4
AL - Albania 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DZ - Algeria 3
ES - Italia 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
RS - Serbia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
IR - Iran 2
LV - Lettonia 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
SR - Suriname 1
Totale 6.400
Salva come PNG Salva come JPEG
Città #
Hong Kong 348
Singapore 343
Fairfield 320
The Dalles 251
Ashburn 206
Woodbridge 157
Princeton 140
Seattle 138
San Jose 127
Wilmington 125
Houston 111
Cambridge 103
Beijing 102
Jacksonville 101
New York 97
Helsinki 83
Istanbul 80
Lauterbourg 80
Dublin 79
Ho Chi Minh City 74
Ann Arbor 57
Hanoi 57
Los Angeles 53
São Paulo 41
Buffalo 36
Redondo Beach 34
San Diego 32
Council Bluffs 29
Des Moines 29
Moscow 28
Chicago 26
Rio de Janeiro 23
Shanghai 21
Orem 19
Chandler 18
London 17
Menlo Park 16
Brussels 15
Curitiba 13
Dallas 13
Santa Clara 12
Belo Horizonte 11
Tashkent 11
Brasília 10
Dhaka 10
Frankfurt am Main 10
Munich 10
Nuremberg 9
Romola 9
Buenos Aires 8
Campinas 8
Düsseldorf 8
Elk Grove Village 8
Haiphong 8
Johannesburg 8
Chennai 7
Contagem 7
Da Nang 7
Milan 7
Paris 7
San Francisco 7
Sorocaba 7
Warsaw 7
Amsterdam 6
Atlanta 6
Guayaquil 6
Kingston 6
Manchester 6
Salt Lake City 6
Salvador 6
Tokyo 6
Brno 5
Brooklyn 5
Chiswick 5
Hải Dương 5
Manaus 5
Montevideo 5
Montreal 5
Norwalk 5
Poplar 5
Praia Grande 5
Recife 5
Stockholm 5
Thái Bình 5
Uberlândia 5
Wandsworth 5
Ankara 4
Boston 4
Brescia 4
Bắc Giang 4
Cairo 4
Changsha 4
Denver 4
Dubai 4
Guangzhou 4
Ha Long 4
Indaiatuba 4
Jeddah 4
Joinville 4
Karachi 4
Totale 4.017
Salva come PNG Salva come JPEG
Nome #
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma 138
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma 117
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors 117
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 108
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 107
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 102
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 101
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 98
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 97
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 96
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine 95
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma 94
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 93
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma 92
⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer 92
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 91
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 89
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 89
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 89
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 88
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection 88
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines 87
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 87
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 87
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy 84
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases 82
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 81
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua 81
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 80
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 80
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma 79
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases 77
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins 77
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy 77
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 76
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 76
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms 76
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 76
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies 76
MicroRNA expression profiling of Xp11 renal cell carcinoma 76
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases 75
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 73
Characterization of human NK cell-derived exosomes: Role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor 73
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 73
Non-small cell lung cancer: land of conquest for immunotherapy 71
Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas 71
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 71
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 71
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy 71
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine 69
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 69
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 69
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes 68
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 66
Artificial intelligence in head and neck cancer diagnosis 65
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 65
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors 65
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression 64
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases 64
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer 64
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 62
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation 61
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 60
Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma 60
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 59
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 59
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 57
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 57
PD-1/pd-l1 in cancer: Pathophysiological, diagnostic and therapeutic aspects 57
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers 55
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 55
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 54
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy 54
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor 54
Exploiting Human NK Cells in Tumor Therapy 52
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 50
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 50
Wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages 50
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells 48
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 48
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy 48
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 46
Pediatric tumors-mediated inhibitory effect on nk cells: The case of neuroblastoma and Wilms’ tumors 44
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review 41
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity 41
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 41
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 40
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? 37
Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies 36
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 33
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects 15
Totale 6.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/2022398 9 44 11 41 4 7 9 56 84 29 34 70
2022/2023263 81 0 6 2 5 89 6 17 32 2 13 10
2023/2024539 17 14 12 96 14 70 11 27 181 2 4 91
2024/20251.240 4 9 11 118 127 84 132 31 163 175 244 142
2025/20262.798 227 421 305 532 182 90 301 113 250 225 120 32
Totale 6.497